AXA S.A. - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 201 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
AXA S.A. ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2020$249,000
-92.5%
10,100
-66.1%
0.00%
-92.3%
Q1 2019$3,328,000
+11.0%
29,7550.0%0.01%0.0%
Q4 2018$2,999,000
-20.2%
29,7550.0%0.01%
-7.1%
Q3 2018$3,760,000
+161.3%
29,755
+20.8%
0.01%
+133.3%
Q4 2017$1,439,000
+0.6%
24,632
-0.1%
0.01%0.0%
Q3 2017$1,431,000
-86.7%
24,648
-72.2%
0.01%
-87.8%
Q2 2017$10,735,000
+3.2%
88,669
-3.6%
0.05%
+4.3%
Q1 2017$10,402,000
+1.0%
91,970
-3.0%
0.05%
-2.1%
Q4 2016$10,299,000
-20.3%
94,789
+20.8%
0.05%
-15.8%
Q3 2016$12,920,000
+8.6%
78,499
-5.8%
0.06%
+7.5%
Q2 2016$11,894,000
-2.0%
83,363
-11.8%
0.05%
-1.9%
Q1 2016$12,136,000
-15.3%
94,464
-1.6%
0.05%
-14.3%
Q4 2015$14,336,000
+1.7%
95,990
+12.9%
0.06%
+8.6%
Q3 2015$14,100,000
-14.5%
85,009
+24.4%
0.06%
-12.1%
Q2 2015$16,491,000
-14.4%
68,3190.0%0.07%
-16.5%
Q1 2015$19,267,000
+103.6%
68,319
+12.7%
0.08%
+107.9%
Q4 2014$9,461,000
+299.7%
60,645
+506.4%
0.04%
+280.0%
Q3 2014$2,367,00010,0000.01%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$14,787,0002.73%
DeepCurrents Investment Group LLC 416,800$9,620,0000.33%
DUALITY ADVISERS, LP 105,668$2,439,0000.21%
EULAV Asset Management 335,000$7,732,0000.21%
Virtus ETF Advisers LLC 19,375$447,0000.19%
Hennion & Walsh Asset Management, Inc. 135,214$3,121,0000.19%
PDT Partners, LLC 110,592$2,552,0000.18%
KETTLE HILL CAPITAL MANAGEMENT, LLC 70,256$1,622,0000.16%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$3,896,0000.12%
WOODWARD DIVERSIFIED CAPITAL, LLC 8,939$206,0000.12%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders